Stay updated with breaking news from Williamc Mobley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers around the world have tried many ways, and for many years, to generate neurons in the lab so they could study them better. Neurons-on-demand might also provide a therapeutic option for replacing neurons lost in neurodegenerative conditions, such as Parkinson's disease.
(0) TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company's scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, an...
The Vatican's Pontifical Council for Culture and The Cura Foundation "Unite to Prevent" Global Leaders in Science, Faith, Medicine and Technology Gather for the Fifth International Vatican Conference News provided by Share this article Share this article VATICAN CITY and NEW YORK, April 15, 2021 /PRNewswire/ -- The Vatican's Pontifical Council for Culture and The Cura Foundation's Fifth International Vatican Conference will be held on May 6-8, 2021. The conference will unite the foremost leading physicians, scientists, leaders of faith, ethicists, patient advocates, policymakers, philanthrop...
Novel Drug Prevents Amyloid Plaques, a Hallmark of Alzheimer’s Disease In animal models, the new compound modulated a key enzyme, reducing or eliminating production of problematic protein fragments; human clinical trials needed March 02, 2021 | Scott LaFee News_release Amyloid plaques are pathological hallmarks of Alzheimer’s disease (AD) — clumps of misfolded proteins that accumulate in the brain, disrupting and killing neurons and resulting in the progressive cognitive impairment that is characteristic of the widespread neurological disorder. In a new study, published M...
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.